Company: AZN
Filing Date: 2025-04-29
Form Type: 6-K
Source: 0001654954-25-004742
Chunk: 4

Company: ASTRAZENECA PLC
Filing Date: 2025-04-29
Form: 6-K
Chunk 4
---
 April 2025.

8. Liu J, et al . Second-Line Hormonal Therapy for the Management of Metastatic Castration-Resistant Prostate Cancer: A Real-World Data Study Using a Claims Database. Sci Rep. 2020;10(1):4240.

#### Adrian Kemp

#### Company Secretary

#### AstraZeneca PLC
<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| AstraZeneca 
 PLC         |

Date: 29 April 2025

| By: /s/           
 Adrian Kemp       |
| Name:             
 Adrian Kemp       |
| Title:            
 Company Secretary |